Literature DB >> 34160488

Recent progress on nanomedicine-induced ferroptosis for cancer therapy.

Hajra Zafar1, Faisal Raza, Siyu Ma, Yawen Wei, Jun Zhang, Qi Shen.   

Abstract

The current treatment strategies for cancer therapy have posed many problems in achieving high efficacy. Therefore, an urgent step is needed to develop innovative therapies that can win beyond satisfactory results against tumor. Ferroptosis that is a kind of non-apoptotic based programmed cell death has played a crucial role in eradicating tumors by reactive oxygen species and iron-dependent pathways. Research shows a remarkable potential of ferroptosis in eliminating aggressive malignancies resistant to traditional therapies. The combination of nanomedicine and ferroptosis has revealed a close relationship for the treatment of various cancer types with high efficacy. This review introduces the basics of nanomedicine-based ferroptosis first to emphasize the feasibility and properties of ferroptosis in cancer therapy. Then, the current research on the applications of nanomedicine for the ferroptosis-based anticancer therapy is highlighted. Finally, conclusions and future research directions in perspective of various challenges in developing nanomedicine-based ferroptosis into clinical therapeutics are discussed.

Entities:  

Year:  2021        PMID: 34160488     DOI: 10.1039/d1bm00721a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  7 in total

Review 1.  New anti-cancer explorations based on metal ions.

Authors:  Han Hu; Qi Xu; Zhimin Mo; Xiaoxi Hu; Qianyuan He; Zhanjie Zhang; Zushun Xu
Journal:  J Nanobiotechnology       Date:  2022-10-23       Impact factor: 9.429

2.  Discovery of Leptulipin, a New Anticancer Protein from theIranian Scorpion, Hemiscorpius lepturus.

Authors:  Ali Rezaei; Saeme Asgari; Samira Komijani; Seyedeh Narjes Sadat; Jean-Marc Sabatier; Davood Nasrabadi; Kamran Pooshang Bagheri; Delavar Shahbazzadeh; Mohammad Reza Akbari Eidgahi; Michel De Waard; Hasan Mirzahoseini
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

3.  The Effects of Chinese Herbal Decoction Combined with Recombinant Human Interferon α2b on MRI Imaging, Tumor Markers, and Immune Function in Patients with Renal Cell Carcinoma.

Authors:  Siliang Song; Wen Li; Wenjuan Liang; Xiu Tian
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

Review 4.  Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.

Authors:  Hui Yan; Bo Zhai; Fang Yang; Zhenliang Chen; Qiang Zhou; Ana Cláudia Paiva-Santos; Ziqiao Yuan; Yang Zhou
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

5.  N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma.

Authors:  Yang Zhou; Xuhui Guan; Shuncong Wang; Huanhuan Sun; Haiqing Ma
Journal:  J Oncol       Date:  2022-09-02       Impact factor: 4.501

Review 6.  Application Perspectives of Nanomedicine in Cancer Treatment.

Authors:  Shanshan Hou; Muhammad Hasnat; Ziwei Chen; Yinong Liu; Mirza Muhammad Faran Ashraf Baig; Fuhe Liu; Zelong Chen
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

7.  Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway.

Authors:  Meng Wang; Qiulin Zhang; Yuehan Li; Lei Jin; Zishui Fang
Journal:  J Oncol       Date:  2022-08-11       Impact factor: 4.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.